Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shu Qiang Weng"'
Autor:
Xia-Hui Lin, Dong-ping Li, Zhi-Yong Liu, Si Zhang, Wen-qing Tang, Rong-xin Chen, Shu-qiang Weng, Yu-jen Tseng, Ru-yi Xue, Ling Dong
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-20 (2023)
Abstract Background Abnormal miRNA and mRNA expression and dysregulated immune microenvironment have been found to frequently induce the progression of hepatocellular carcinoma (HCC) in recent reports. In particular, the immune-related competing endo
Externí odkaz:
https://doaj.org/article/b884d597764c49a8967e933a458f38bb
Autor:
Xia-Hui Lin, Zhi-Yong Liu, Dan-Ying Zhang, Si Zhang, Wen-Qing Tang, Dong-Ping Li, Feng Zhang, Rong-Xin Chen, Shu-Qiang Weng, Ru-Yi Xue, Ling Dong
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-21 (2022)
Abstract Background Though circular RNAs (circRNAs) are the key regulators in tumor carcinogenesis, they remain largely unexplored in hepatocellular carcinoma (HCC). Methods The expression of RanGAP1-derived circRNAs (circ_0063531, circ_0063534, circ
Externí odkaz:
https://doaj.org/article/d1fb2f7f57084b5d83306be6825f33a0
Autor:
Jia-Lei Sun, Ning-Ping Zhang, Ru-Chen Xu, Guang-Cong Zhang, Zhi-Yong Liu, Weinire Abuduwaili, Fu Wang, Xiang-Nan Yu, Xuan Shi, Guang-Qi Song, Hao Wu, Tao-Tao Liu, Xi-Zhong Shen, Bin Deng, Shu-Qiang Weng, Ling Dong, Ji-Min Zhu
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-15 (2021)
Abstract Background Tumor-associated macrophages (TAM) are immunosuppressive cells that contribute to impaired anti-cancer immunity. Iron plays a critical role in regulating macrophage function. However, it is still elusive whether it can drive the f
Externí odkaz:
https://doaj.org/article/7365da9498c843459afe01b50db19d7f
Autor:
Zhi-Yong Liu, Dan-Ying Zhang, Xia-Hui Lin, Jia-Lei Sun, Weinire Abuduwaili, Guang-Cong Zhang, Ru-Chen Xu, Fu Wang, Xiang-Nan Yu, Xuan Shi, Bin Deng, Ling Dong, Shu-Qiang Weng, Ji-Min Zhu, Xi-Zhong Shen, Tao-Tao Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Sorafenib resistance is often developed and impedes the benefits of clinical therapy in hepatocellular carcinoma (HCC) patients. However, the relationship between sorafenib resistance and tumor immune environment and adjuvant drugs for sorafenib-resi
Externí odkaz:
https://doaj.org/article/027f3ea33be04898b7b15cd031fd13e2
Autor:
Zhi-Yong Liu, Xia-Hui Lin, Hong-Ying Guo, Xuan Shi, Dan-Ying Zhang, Jia-Lei Sun, Guang-Cong Zhang, Ru-Chen Xu, Fu Wang, Xiang-Nan Yu, Dou Wang, Shu-Qiang Weng, Xi-Zhong Shen, Tao-Tao Liu, Ling Dong, Ji-Min Zhu
Publikováno v:
International Journal of Biological Sciences; 2024, Vol. 20 Issue 7, p2763-2778, 16p
Autor:
Weinire Abuduwaili, Xiang Wang, An-Tian Huang, Jia-Lei Sun, Ru-Chen Xu, Guang-Cong Zhang, Zhi-Yong Liu, Fu Wang, Chang-Feng Zhu, Tao-Tao Liu, Ling Dong, Ji-Min Zhu, Shu-Qiang Weng, Yuhao Li, Xi-Zhong Shen
Publikováno v:
ACS applied materialsinterfaces. 14(33)
Although sorafenib, a multi-kinase inhibitor, has provided noteworthy benefits in patients with hepatocellular carcinoma (HCC), the inevitable side effects, narrow therapeutic window, and low bioavailability seriously affect its clinical application.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c1bf842f95993f4bed1ba4abbe8578
https://pubmed.ncbi.nlm.nih.gov/35951459
https://pubmed.ncbi.nlm.nih.gov/35951459
Autor:
Harry L.A. Janssen, Yu Cai, Ling Dong, Hai‑Rong Zhu, Li‑Li Liu, Jian Wu, Enkhnaran Bilegsaikhan, Xiang‑Nan Yu, Ji‑Min Zhu, Xuan Shi, Shu Qiang Weng, Hong‑Ying Guo, Xi Zhong Shen, Tao Tao Liu, Guang‑Cong Zhang, Guang‑Qi Song
Publikováno v:
International Journal of Molecular Medicine
Long non‑coding RNAs (lncRNAs) have been shown to contribute to progression and prognosis of hepatocellular carcinoma (HCC). However, expression profiling and interaction of lncRNAs with messenger RNAs (mRNAs) and microRNAs (miRNAs) remain largely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f7bc7dc1c22770e94155e8df3b44f5
http://europepmc.org/articles/PMC6777664
http://europepmc.org/articles/PMC6777664
Autor:
Xuan, Shi, Tao-Tao, Liu, Xiang-Nan, Yu, Asha, Balakrishnan, Hai-Rong, Zhu, Hong-Ying, Guo, Guang-Cong, Zhang, Enkhnaran, Bilegsaikhan, Jia-Lei, Sun, Guang-Qi, Song, Shu-Qiang, Weng, Ling, Dong, Michael, Ott, Ji-Min, Zhu, Xi-Zhong, Shen
Publikováno v:
Oncogene. 39(35)
Cumulative evidence suggests that microRNAs (miRNAs) promote gene expression in cancers. However, the pathophysiologic relevance of miRNA-mediated RNA activation in hepatocellular carcinoma (HCC) remains to be established. Our previous miRNA expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a6e3150fdba2eb93f14a32507d3e47d
https://pubmed.ncbi.nlm.nih.gov/32719439
https://pubmed.ncbi.nlm.nih.gov/32719439
Publikováno v:
Journal of Digestive Diseases. 16:159-163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed0b88162590044da666cb74da4bee9d
https://doi.org/10.1111/1751-2980.12189
https://doi.org/10.1111/1751-2980.12189
Autor:
Hai-Rong Zhu, Ren-Zheng Huang, Xiang-Nan Yu, Xuan Shi, Bilegsaikhan, Enkhnaran, Hong-Ying Guo, Guang-Qi Song, Shu-Qiang Weng, Ling Dong, Janssen, Harry L. A., Xi-Zhong Shen, Ji-Min Zhu
Publikováno v:
Tohoku Journal of Experimental Medicine; Jun2018, Vol. 245 Issue 2, p89-98, 10p